NP432113.RAhGKXfsq jY25Yqu9-CkNezGTX5-du9eMt43Qo-exV4I
has assertion: NP432113.RAhGKXfsq jY25Yqu9-CkNezGTX5-du9eMt43Qo-exV4I130 assertion
has provenance: NP432113.RAhGKXfsq jY25Yqu9-CkNezGTX5-du9eMt43Qo-exV4I130 provenance
has publication info: NP432113.RAhGKXfsq jY25Yqu9-CkNezGTX5-du9eMt43Qo-exV4I130 publicationInfo
type: Nanopublication
created: 2016-05-13T12:45:01+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP432113.RAhGKXfsq jY25Yqu9-CkNezGTX5-du9eMt43Qo-exV4I130 assertion
type: Assertion
description: [Loss of PML protein expression was associated with tumor progression in prostate cancer (the progression from prostatic intraepithelial neoplasia to invasive carcinoma was associated with complete PML loss; P<.001), breast cancer (complete PML loss was associated with lymph node metastasis; P =.01), and CNS tumors (complete PML loss was associated with high-grade tumors; P =.003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/14970276
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0